Navigation Links
CareFusion Reports First Quarter Fiscal 2012 Results
Date:11/7/2011

h and Development Expenses40--40Restructuring and Acquisition Integration Charges 22-(22)-Operating Income79-39118Interest Expense and Other, Net 23--23Income Before Income Tax56-3995Provision for Income Taxes20-1131Income from Continuing Operations36-2864Income from Discontinued Operations, Net of Tax2(2)---Net Income

$

38

$

(2)

$

28

$

64.Per Share Amounts:(4)Basic Earnings per Common Share

$

0.17

$

(0.01)

$

0.13

$

0.29Diluted Earnings per Common Share

$

0.17

$

(0.01)

$

0.13

$

0.29Weighted-Average Number of Common Shares Outstanding:Basic222.1222.1222.1222.1Diluted223.9223.9223.9223.9Effective Tax Rate34.4%n/a27.8%31.7%____________1Reflects the impact of the divestiture of the International Surgical Products (ISP) business.  The ISP business was divested in April 2011, and has been classified as discontinued operations. 2Reflects nonrecurring charges primarily related to the spinoff, nonrecurring restructuring and acquisition integration charges, and nonrecurring tax items.  3Adjusted financial information reflects GAAP results adjusted on a non-GAAP basis to exclude nonrecurring items noted.4Earnings per share calculations are performed separately for each adjustment presented.  Therefore, the sum of the per share adjustments from the table above may not equal the adjusted per share totals presented. CAREFUSION CORPORATIONADJUSTED SEGMENT FINANCIAL INFORMATION(UNAUDITED)Quarter Ended September 30, 2011Nonrecurring(in millions)GAAP Items(1)Adjusted(3)Medical SystemsRevenue$

509

$

-

$

509Operating Income $

88

$

7

$

95Procedural SolutionsRevenue$

335

$

-

$

335Operating Income $

20

$

4

$

24Quarter Ended September 30, 2010No
'/>"/>

SOURCE CareFusion
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. ERT Closes the Acquisition of the Research Services Division of CareFusion Corporation
2. Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011
3. InterMune Reports Third Quarter 2011 Financial Results and Business Highlights
4. Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results
5. Optimer Pharmaceuticals Reports Third Quarter 2011 Financial Results
6. Caliper Life Sciences Reports Third Quarter 2011 Results
7. Neurocrine Biosciences Reports Third Quarter 2011 Results
8. United Therapeutics Corporation Reports Third Quarter 2011 Financial Results
9. Sangamo BioSciences Reports Third Quarter 2011 Financial Results
10. Cell Therapeutics, Inc. (CTI) Reports Third Quarter Financial Results and Milestones
11. ReportsnReports: Depression Therapeutics Market to Reach $10.9 Billion by 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)...  Neurotech Pharmaceuticals, Inc., announced today the first ... 2 clinical trial of NT-503 Encapsulated Cell Therapy ... choroidal neovascularization secondary to age related macular degeneration ... growth factor (VEGF) receptor protein continuously produced by ... proof-of-concept study will evaluate NT-503 ECT as a ...
(Date:9/2/2015)... ZIONA, Israel , September 2, 2015 /PRNewswire/ ... today announced the intent of the National Institute of Allergy ... of Health (NIH) within the Department of Health and Human ... be held in the United States ... of BiondVax,s universal flu vaccine candidate, Multimeric-001 (M-001), as a ...
(Date:9/2/2015)... ... 02, 2015 , ... The TS5-Q is designed for myriad ... to analysis of athletic performance. Producing high-resolution slow-motion video , the TS5-Q ... process with the naked eye. , Slow motion sequences are commonly seen ...
(Date:9/1/2015)... 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... of targeted antiviral therapies, announced today that it will ... Annual Global Investment Conference sponsored by H.C. Wainwright ... The St. Regis Hotel in New York, ... , Chief Executive Officer, will provide an overview of ...
Breaking Biology Technology:Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2
... how they view the Viasys Healthcare's NeuroCare Group, ... about the growth potential of the Fitchburg-based organization. , ,As ... Healthcare, Cardinal Health would acquire Viasys, parent of the NeuroCare ... of directors. , ,In a conference call with investors, ...
... contrarian move, the family-focused Web hosting and social networking site ... advertising and move to a subscription-only business model. The move ... announcement. , ,We find that families do not want ... Wayne Naphtal. , ,Interestingly, Web businesses have yet to find ...
... - In retail terms, a loss leader is merchandise ... sales of other items on the shelves. A store owner ... but make up for it handsomely through other sales. , ... cells. No one is making much money - yet - ...
Cached Biology Technology:Cardinal Health likes growth potential of Viasys NeuroCare Group 2Cardinal Health likes growth potential of Viasys NeuroCare Group 3Delivering value instead of advertising - what a concept! 2Delivering value instead of advertising - what a concept! 3Stem cells get most attention, but they are only part of Wisconsin's bio-portfolio 2Stem cells get most attention, but they are only part of Wisconsin's bio-portfolio 3Stem cells get most attention, but they are only part of Wisconsin's bio-portfolio 4
(Date:7/31/2015)... Kina, 31. juli 2015 Den 10. internationale ... af BGI fra den 22. - 25. oktober i ... fejrer sin 10-års fødselsdag i år. Siden starten i ... årlige møder på ,omik,-feltet, og er en af de ... ICG-10 fokuserer på nylige gennembrud og fremskridt inden ...
(Date:7/31/2015)... julho de 2015 A 10 a. ... realizada pela BGI de 22-25 de outubro de 2015, em ... A conferência está celebrando seu 10 o. aniversário este ... tornou uma das reuniões mais influentes do mundo no ... dinâmicos, entusiastas e prazerosos. A ICG-10 ...
(Date:7/31/2015)... , 31 de julio de 2015 La ... ) se celebrará por medio de BGI del 22 al 25 ... . Este año, la conferencia celebra su ... se ha convertido en una de las reuniones anuales más ... una de las reuniones más dinámicas, entusiastas y mejores a ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... some repetitive DNA sequences can make human chromosomes "fragile," ... Scientists at Tufts University have found that one such ... but also thwarts the cell,s capacity to repair and ... because it is associated with hereditary neurological disorders such ...
... Researchers at Mayo Clinic have discovered the first gender-linked ... the Jan. 11 online edition of Nature Genetics ... association study of patients with Alzheimer,s disease. The research ... variant in the PCDH11X gene, found on the X ...
... MADISON University of Wisconsin-Madison researchers have solved the mystery ... release of neurotransmitters and hormones in the brain. ... whose main location and function were unknown until now ... at a control knob, the protein may adjust the release ...
Cached Biology News:Biologists discover link between CGG repeats in DNA and neurological disorders 2Mayo: Variants in gene on X chromosome associated with increased susceptibility to Alzheimer's 2Mayo: Variants in gene on X chromosome associated with increased susceptibility to Alzheimer's 3Protein that regulates hormones critical to women's health found in pituitary 2Protein that regulates hormones critical to women's health found in pituitary 3
TRBP1 Antibody...
Complete cell culture media with cytokines...
Complete cell culture media with cytokines...
Consists of 4 separate 100mM solutions (ATP,GTP,CTP and UTP pH 7.5) as sodium salts. 98% Pure by HPLC...
Biology Products: